SCHEMBL23630872

SCHEMBL23630872

Clc1ccccc1-c1ncccc1Br

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.57
KCNA5 P22460 3/20 0.46
HSD11B1 P28845 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
CDC25B P30305 2/20 0.43
S100A4 P26447 1/20 0.43
LIMK1 P53667 1/20 0.42
PTPRC P08575 2/20 0.41
CTSL P07711 1/20 0.41
CTSS P25774 1/20 0.41
PTPN13 Q12923 1/20 0.41
TDP2 O95551 1/20 0.41
NSD2 O96028 1/20 0.41
ABL1 P00519 1/20 0.41
PLCG1 P19174 1/20 0.41
CES1 P23141 1/20 0.41
PAX8 Q06710 1/20 0.41
RIN1 Q13671 1/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31507437 0.84 CDC25B (0.48) CDC25BS100A4PTPRCCTSLCTSS
SCHEMBL20821396 0.84 DPP4 (0.65) DPP4KCNA5SMN1; SMN2CDC25BS100A4
SCHEMBL15672965 0.82 IDO1 (0.41) DPP4KCNA5SMN1; SMN2CDC25BS100A4
SCHEMBL27768716 0.77 CDC25B (0.43) CDC25BS100A4PTPRCCTSLCTSS
SCHEMBL1207550 0.77 DPP4 (0.57) DPP4KCNA5HSD11B1CDC25BS100A4
SCHEMBL27267136 0.77 DPP4 (0.57) DPP4KCNA5SMN1; SMN2CDC25BS100A4
SCHEMBL23636188 0.77 CYP2A6 (0.59) DPP4KCNA5HSD11B1CDC25BS100A4
SCHEMBL15638059 0.77 S100A4 (0.40) DPP4CDC25BS100A4PTPRCCTSL
SCHEMBL7772699 0.76 CDC25B (0.46) SMN1; SMN2CDC25BS100A4PTPRCCTSL
SCHEMBL29666462 0.76 CDC25B (0.46) SMN1; SMN2CDC25BS100A4PTPRCCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12201013-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2025-01-14 US disclosed
US-20210217970-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-07-15 US disclosed
CN-1774247-A Novel compounds SMITHKLINE BEECHAM CORP (US) 2006-05-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210217970-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES L1CAM, EPCAM, OR10J3 DPP4 2732/4885KCNA5 499/4885HSD11B1 4520/4885
US-12201013-B2 Organic electroluminescent materials and devices L1CAM, SOD1, EPCAM DPP4 4385/4885KCNA5 347/4885HSD11B1 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.